UCL Queen Square Institute of Neurology




The Leonard Wolfson Experimental Neurology Centre was made possible through the extraordinary support of the Wolfson Foundation, as a legacy to former chairman Lord Wolfson

In December 2011, the Wolfson Foundation awarded £20 million to UCL to establish The Leonard Wolfson Experimental Neurology Centre, a new experimental neurology clinical facility and training programme, aimed at the understanding and treatment of neurodegenerative diseases. The grant is the largest single award ever made by the Foundation and one of the largest philanthropic donations in UCL’s history.

The LWENC Clinical Research Facility opened in November 2013 and is based at the heart of the National Hospital for Neurology and Neurosurgery (NHNN), the partner hospital of the UCL Institute of Neurology, reflecting the importance of bringing together clinical and scientific excellence in the search for effective treatments for these devastating diseases.

Centre Aims

The highest priority for patients with neurodegenerative diseases is to find treatments that slow or halt disease progression. These treatments should be offered as early as possible to have maximum impact on loss of cognitive and neurological function. The LWENC aims to:
  1. Accelerate the development and validation of treatments
  2. Open an earlier therapeutic window for intervention
  3. Horizon scan for future therapeutic targets